Dr Reddys Laboratories Share Price Today - Live Blog for May 19, 2025

The stock of Dr Reddys Laboratories Ltd suffered a -0.22% drop, and it's now trading at ₹1,218.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

With a -0.24% decrease, Dr Reddys Laboratories Ltd's share price is now at ₹1,217.40. The stock is currently trading at a PE of 17.8100, while the industry PE is 33.6308, prompting investors to assess its value proposition.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.33% upswing, and it's currently trading at ₹1,220.95 per share. Investors are closely watching this development.

The share price of Dr Reddys Laboratories Ltd has plummeted by -0.16%, signalling a challenging period. Currently trading at ₹1,216.90, this stock has caught the eye of bargain hunters, who may be considering their entry points.

Dr Reddys Laboratories Ltd's stock price surged by 0.15%, reaching the current market value of ₹1,218.80 per share. This surge is a testament to the stock's recent performance.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.02% uptick in its share price. As a result, it's now actively trading at ₹1,217.00 per share, making it an attractive option for investors.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.17% drop, and it's now trading at ₹1,216.65 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

The stock of Dr Reddys Laboratories Ltd suffered a -0.10% drop, and it's now trading at ₹1,218.75 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

In the financial arena, Dr Reddys Laboratories Ltd's stock price has increased by 0.06%, with its current market value per share resting at ₹1,220.00. This development highlights the stock's appeal to investors.

With a remarkable 0.19% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,219.30. Notably, this stock has a Price-to-Earnings (PE) ratio of 17.8100, while the industry's PE ratio is 33.6308.

After a -0.32% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,218.00. The stock has a PE ratio of 17.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's stock has surged by 0.17%, and it is currently trading at ₹1,223.75. Additionally, the stock maintains a PE ratio of 17.8100, while the industry PE is 33.6308.

After a significant 0.36% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,221.65 in the current market. This upward movement is attracting attention from both retail and institutional investors.

After a -0.09% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,217.25. The stock has a PE ratio of 17.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd's share price has dropped by -0.48%, a development that warrants careful analysis. Presently trading at ₹1,218.35, investors are assessing whether this presents an opportunity or a risk.

After a significant 0.18% gain, Dr Reddys Laboratories Ltd's shares are now valued at ₹1,222.95 in the current market. This upward movement is attracting attention from both retail and institutional investors.

Dr Reddys Laboratories Ltd observed a -0.03% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,220.80. The stock has a PE ratio of 17.8100, an ROE of 16.8559% and a debt to equity ratio of 0.1394.

Dr Reddys Laboratories Ltd shares experienced a -0.01% reduction, with the current market price at ₹1,224.85. Investors are carefully considering their positions and seeking insights into the stock's future performance.

Dr Reddys Laboratories Ltd witnessed a -0.01% drop in its share price and is currently trading at ₹1,224.85. With the stock's PE at 17.8100 and the industry PE at 33.6308, investors are weighing their options.

Dr Reddys Laboratories Ltd shares experienced a -0.39% reduction, with the current market price at ₹1,226.65. Investors are carefully considering their positions and seeking insights into the stock's future performance.